Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drugs & Therapy Perspectives
Published in: Drugs & Therapy Perspectives 3/2006

01-03-2006 | Disease Management

Lifestyle changes are the key to treating exercise-induced hypothalamic amenorrhoea in young female athletes

Published in: Drugs & Therapy Perspectives | Issue 3/2006

Login to get access

Excerpt

Young female athletes have an increased risk of alterations of the hypothalamic-pituitary-ovarian (HPO) axis, resulting in a decrease in estrogen production and bone mineralisation. Disruption of the HPO axis appears to be dependent on the body’s recognition of a negative energy balance, which may be restored through decreases in exercise regimens and changes in diet. …
Literature
1.
Stafford DEJ. Altered hypothalamic-pituitary-ovarian axis function in young female athletes: implications and recommendations for management. Treat Endocrinol 2005; 4(3): 147–54PubMedCrossRef
2.
Emans SJ. Delayed puberty and menstrual irregularities. In: Emans SJ, Laufer MR, Goldstein DP, editors. Pediatric and adolescent gynecology. Philadelphia (PA): Lippincott Williams and Wilkins, 1998: 163–262
3.
Loucks AB, Verdun M, Heath EM. Low energy availability, not stress of exercise, alters LH pulsatility in exercising women. J Appl Physiol 1998; 84(1): 37–46PubMed
4.
Laughlin GA, Yen SSC. Nutritional and endocrine-metabolic aberrations in amenorrheic athletes. J Clin Endocrinol Metab 1996; 81(12): 4301–9PubMedCrossRef
5.
Moschos S, Chan KL, Mantzoros CS. Leptin and reproduction: a review. Fertil Steril 2002; 77(3): 433–44PubMedCrossRef
6.
Mantzoros CS, Flier JS, Rogel AD. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys: V. Rising leptin levels may signal the onset of puberty. J Clin Endocrinol Metab 1997; 82: 1066–70PubMedCrossRef
7.
De Souza MJ, Leidy HJ, O’Donnell E, et al. Fasting ghrelin levels in physically active women: relationship with menstrual disturbances and metabolic hormones. J Clin Endocrinol Metab 2004; 89: 3536–42PubMedCrossRef
8.
Yeager KK, Agostini R, Nattiv A, et al. The female athlete triad: disordered eating, amenorrhea, osteoporosis. Med Sci Sports Exerc 1993; 25: 775–7PubMedCrossRef
9.
Gordon CM, Nelson LM. Amenorrhea and bone health in adolescents and young women. Curr Opin Obstet Gynecol 2003; 15: 377–84PubMedCrossRef
10.
Anderson SJ, Griesemer BA, Johnson MD, et al. Medical concerns in the female athlete. Pediatrics 2000; 106(3): 610–3CrossRef
11.
Hobart JA. The female athlete triad. Am Fam Physician 2000; 61(11): 3357–64PubMed
12.
Warren MP. Health issues in women athletes: exercise-induced amenorrhea. J Clin Endocrinol Metab 1999; 84(6): 1892–6PubMedCrossRef
13.
Greydanus DE, Patel DR. The female athlete: before and beyond puberty. Pediatr Clin North Am 2002; 49(3): 553–80PubMedCrossRef
14.
Warren MP, Perlroth NF. Hormones and sports: the effects of intense exercise on the female reproductive system. J Endocrinol 2001; 170: 3–11PubMedCrossRef
15.
Cumming D. Exercise-associated amenorrhea, low bone density and estrogen replacement therapy. Arch Intern Med 1996; 156: 2193–5PubMedCrossRef
Metadata
Title
Lifestyle changes are the key to treating exercise-induced hypothalamic amenorrhoea in young female athletes
Publication date
01-03-2006
Publisher
Springer International Publishing
Published in
Drugs & Therapy Perspectives / Issue 3/2006
Print ISSN: 1172-0360
Electronic ISSN: 1179-1977
DOI
https://doi.org/10.2165/00042310-200622030-00003

Other articles of this Issue 3/2006

Drugs & Therapy Perspectives 3/2006 Go to the issue

Drug Reactions and Interactions

Use of selective serotonin reuptake inhibitors during pregnancy and breastfeeding has both benefits and risks

Disease Management

Potent topical and/or systemic corticosteroids are first-line treatment of bullous pemphigoid

Drug and Profile Reports

Ramelteon: profile report

Drug and Profile Reports

Acamprosate facilitates the maintenance of abstinence in alcohol-dependent patients after alcohol withdrawal

Disease Management

Management of SARS relies on supportive measures and preventing the spread of infection

Drug Reactions and Interactions

First reports of serious adverse drug reactions in recent weeks